AB-007

N/A

Report date: 2022/01/05 10:50:13

Base Information

Drug NameAB-007
Drug Alias NameAB007Lyme disease nAbs (Aegis Life)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAegis Life Inc
China Registration ClassN/A

Develop Information

Active CompaniesAegis Life Inc
Inactive CompaniesN/A
Active IndicationsLyme Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A